1-3 of 3
Robert Godal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Blocking Inhibitory KIR Is Insufficient for Optimal Killing of AML and ALL Targets: Additional Requirements for NKG2A and LIR-1 Blockade

Robert Godal, Michelle Gleason, Valarie McCullar, Sarah Cooley, MD, Veronika Bachanova, Michael Verneris, MD, Philip McGlave, MD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2008) 112 (11): 2906.
https://doi.org/10.1182/blood.V112.11.2906.2906
Published: 2008
Journal Articles

Killer Immunoglobulin Receptor (KIR) Negative NK Cells Exhibit Potent Alloreactivity Against Primary Leukemia Targets When Interrupting MHC Class I Interactions through NKG2A Blockade.

Robert Godal, MD, Michelle Gleason, Valarie McCullar, Sarah Cooley, MD, Michael Verneris, MD, Philip McGlave, MD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2007) 110 (11): 2862.
https://doi.org/10.1182/blood.V110.11.2862.2862
Published: 2007
Journal Articles

Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2

Robert Godal, Ulrich Keilholz, Lutz Uharek, Anne Letsch, Anne Marie Asemissen, Antonia Busse, Il-Kang Na, Eckhard Thiel, Carmen Scheibenbogen
Journal: Blood
Blood (2006) 107 (8): 3205–3211.
https://doi.org/10.1182/blood-2005-07-2880
Published: 2006